Drug ID: | NPD6349 |
Drug Name: | Oprozomib; ONX-0912 |
Molecular Formula: | C25H32N4O7S |
Canonical SMILES: | COC[C@@H](C(=N[C@H](C(=O)[C@]1(C)OC1)Cc1ccccc1)O)N=C([C@@H](N=C(c1cnc(s1)C)O)COC)O |
Standard InCHI: | InChI=1S/C25H32N4O7S/c1-15-26-11-20(37-15)24(33)29-19(13-35-4)23(32)28-18(12-34-3)22(31)27-17(21(30)25(2)14-36-25)10-16-8-6-5-7-9-16/h5-9,11,17-19H,10,12-14H2,1-4H3,(H,27,31)(H,28,32)(H,29,33)/t17-,18-,19-,25+/m0/s1 |
Standard InCHIKey: | SWZXEVABPLUDIO-WSZYKNRRSA-N |
Max Developmental Stage: | Phase 1 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB001224 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 532.20 |
ALogP | -0.3439 |
MLogP | 2.89 |
XLogP | 1.88 |
HDA | 11 |
HBD | 3 |
Rotatable Bonds | 21 |
TPSA | 186.96 |
RO5 Violation | 2 |